Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Hong Kong
· Delayed Price · Currency is HKD 0.125
+0.001 (0.81%)
Apr 29, 2026, 3:58 PM HKT
HKG:8329 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 972.01 | 1,042 | 1,065 | 986.69 | 838.81 | Upgrade
|
| Revenue Growth (YoY) | -6.69% | -2.17% | 7.92% | 17.63% | -18.67% | Upgrade
|
| Cost of Revenue | 684.79 | 713.66 | 625.62 | 543.01 | 470.67 | Upgrade
|
| Gross Profit | 287.22 | 328.04 | 439.24 | 443.68 | 368.13 | Upgrade
|
| Selling, General & Admin | 231.33 | 256.27 | 343.26 | 337.96 | 318.65 | Upgrade
|
| Other Operating Expenses | 24.06 | 32.74 | 45 | 17.45 | 11.3 | Upgrade
|
| Operating Expenses | 266.65 | 293.26 | 391.07 | 358.26 | 332.38 | Upgrade
|
| Operating Income | 20.57 | 34.78 | 48.18 | 85.42 | 35.75 | Upgrade
|
| Interest Expense | -4.14 | -5.08 | -5.57 | -7.03 | -4.6 | Upgrade
|
| Interest & Investment Income | 2.02 | 3.65 | 6.26 | 6.47 | 8.22 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.76 | 0 | 0.05 | 0.02 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.63 | -0.82 | -0.32 | 0.01 | -0.58 | Upgrade
|
| EBT Excluding Unusual Items | 16.58 | 32.54 | 48.59 | 84.9 | 38.83 | Upgrade
|
| Impairment of Goodwill | -63.42 | - | -33.1 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.11 | -2.89 | -1.01 | -2.64 | -0.58 | Upgrade
|
| Asset Writedown | -1.61 | - | 16.2 | - | 0.86 | Upgrade
|
| Pretax Income | -48.56 | 29.64 | 30.67 | 82.26 | 39.11 | Upgrade
|
| Income Tax Expense | 4.54 | 15.88 | 16.15 | 18.43 | 4.8 | Upgrade
|
| Earnings From Continuing Operations | -53.1 | 13.77 | 14.53 | 63.83 | 34.31 | Upgrade
|
| Minority Interest in Earnings | 12.36 | 11.25 | 9.6 | -9.48 | 1.65 | Upgrade
|
| Net Income | -40.74 | 25.01 | 24.13 | 54.35 | 35.96 | Upgrade
|
| Net Income to Common | -40.74 | 25.01 | 24.13 | 54.35 | 35.96 | Upgrade
|
| Net Income Growth | - | 3.68% | -55.61% | 51.14% | -1.73% | Upgrade
|
| Shares Outstanding (Basic) | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 | Upgrade
|
| Shares Outstanding (Diluted) | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 | Upgrade
|
| EPS (Basic) | -0.02 | 0.01 | 0.01 | 0.03 | 0.02 | Upgrade
|
| EPS (Diluted) | -0.02 | 0.01 | 0.01 | 0.03 | 0.02 | Upgrade
|
| EPS Growth | - | 3.68% | -55.61% | 51.14% | -1.73% | Upgrade
|
| Free Cash Flow | - | 5.28 | 38.47 | 41.53 | -81.64 | Upgrade
|
| Free Cash Flow Per Share | - | 0.00 | 0.02 | 0.03 | -0.05 | Upgrade
|
| Dividend Per Share | - | 0.005 | - | - | - | Upgrade
|
| Gross Margin | 29.55% | 31.49% | 41.25% | 44.97% | 43.89% | Upgrade
|
| Operating Margin | 2.12% | 3.34% | 4.52% | 8.66% | 4.26% | Upgrade
|
| Profit Margin | -4.19% | 2.40% | 2.27% | 5.51% | 4.29% | Upgrade
|
| Free Cash Flow Margin | - | 0.51% | 3.61% | 4.21% | -9.73% | Upgrade
|
| EBITDA | 49.09 | 63.3 | 76.26 | 114.25 | 61.04 | Upgrade
|
| EBITDA Margin | 5.05% | 6.08% | 7.16% | 11.58% | 7.28% | Upgrade
|
| D&A For EBITDA | 28.52 | 28.52 | 28.08 | 28.82 | 25.29 | Upgrade
|
| EBIT | 20.57 | 34.78 | 48.18 | 85.42 | 35.75 | Upgrade
|
| EBIT Margin | 2.12% | 3.34% | 4.52% | 8.66% | 4.26% | Upgrade
|
| Effective Tax Rate | - | 53.57% | 52.64% | 22.41% | 12.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.